FHA
HQL

Flagship Harbor Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.38M Buy
341,959
+1,082
+0.3% +$13.9K 0.21% 113
2025
Q1
$4.33M Buy
340,877
+90,436
+36% +$1.15M 0.23% 97
2024
Q4
$3.29M Sell
250,441
-62,502
-20% -$820K 0.17% 117
2024
Q3
$4.72M Buy
+312,943
New +$4.72M 0.26% 85
2024
Q1
$3.87M Buy
283,829
+19,826
+8% +$270K 0.25% 90
2023
Q4
$3.55M Buy
264,003
+32,545
+14% +$438K 0.26% 84
2023
Q3
$2.89M Buy
231,458
+207
+0.1% +$2.58K 0.24% 97
2023
Q2
$3.13M Sell
231,251
-135,868
-37% -$1.84M 0.26% 91
2023
Q1
$5.11M Sell
367,119
-366
-0.1% -$5.1K 0.48% 47
2022
Q4
$5.22M Buy
367,485
+11,802
+3% +$168K 0.54% 39
2022
Q3
$4.86M Buy
355,683
+9,986
+3% +$136K 0.56% 36
2022
Q2
$4.92M Buy
345,697
+6,514
+2% +$92.7K 0.55% 36
2022
Q1
$5.61M Buy
339,183
+4,454
+1% +$73.7K 0.54% 35
2021
Q4
$6.44M Buy
334,729
+10,494
+3% +$202K 0.61% 28
2021
Q3
$6.95M Hold
324,235
0.75% 22
2021
Q2
$6.95M Buy
324,235
+1,922
+0.6% +$41.2K 0.75% 22
2021
Q1
$6.35M Buy
322,313
+17,836
+6% +$352K 0.72% 20
2020
Q4
$6.01M Buy
304,477
+11,082
+4% +$219K 0.75% 19
2020
Q3
$5.16M Buy
293,395
+8,235
+3% +$145K 0.7% 20
2020
Q2
$5.12M Buy
285,160
+7,616
+3% +$137K 0.75% 19
2020
Q1
$4.16M Buy
277,544
+844
+0.3% +$12.6K 0.83% 20
2019
Q4
$4.82M Sell
276,700
-4,893
-2% -$85.3K 0.84% 17
2019
Q3
$4.25M Buy
281,593
+6,920
+3% +$104K 0.83% 17
2019
Q2
$4.63M Buy
274,673
+6,854
+3% +$115K 0.96% 13
2019
Q1
$4.59M Buy
267,819
+13,559
+5% +$232K 0.94% 13
2018
Q4
$3.84M Buy
254,260
+4,938
+2% +$74.6K 0.93% 15
2018
Q3
$5.07M Buy
249,322
+1,248
+0.5% +$25.4K 0.94% 10
2018
Q2
$4.66M Buy
248,074
+16,842
+7% +$316K 0.93% 11
2018
Q1
$4.26M Buy
231,232
+20,912
+10% +$385K 1.27% 7
2017
Q4
$4.18M Buy
210,320
+9,059
+5% +$180K 1.2% 10
2017
Q3
$4.44M Buy
201,261
+9,152
+5% +$202K 1.44% 10
2017
Q2
$4.02M Buy
192,109
+13,740
+8% +$288K 1.4% 7
2017
Q1
$3.44M Buy
178,369
+13,715
+8% +$264K 1.31% 8
2016
Q4
$2.91M Buy
+164,654
New +$2.91M 1.26% 9